Jpmorgan Chase & CO Haleon PLC Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Haleon PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 6,014,903 shares of HLN stock, worth $58.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,014,903
Previous 5,084,202
18.31%
Holding current value
$58.4 Million
Previous $53.8 Million
6.9%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding HLN
# of Institutions
659Shares Held
432MCall Options Held
269KPut Options Held
40.6K-
Dodge & Cox San Francisco, CA179MShares$1.74 Billion1.07% of portfolio
-
Clearbridge Investments, LLC New York, NY32.8MShares$319 Million0.26% of portfolio
-
Harding Loevner LP Bridgewater, NJ24.1MShares$234 Million1.6% of portfolio
-
Wellington Management Group LLP Boston, MA15.3MShares$149 Million0.03% of portfolio
-
Morgan Stanley New York, NY9.89MShares$96 Million0.01% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $44.8B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...